These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 31564873

  • 1. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
    Abd El Hady WE, Mohamed EA, Soliman OAE, El-Sabbagh HM.
    Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
    [Abstract] [Full Text] [Related]

  • 2. Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical "apocynin".
    Anter HM, Abu Hashim II, Awadin W, Meshali MM.
    Int J Nanomedicine; 2019; 14():4911-4929. PubMed ID: 31456637
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S, Koli U, Dharamdasani V, Jain R, Dandekar P.
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q.
    Nanotechnology; 2013 Jun 21; 24(24):245101. PubMed ID: 23702815
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations.
    Zhang Y, Zhang R, Illangakoon UE, Harker AH, Thrasivoulou C, Parhizkar M, Edirisinghe M, Luo CJ.
    Int J Nanomedicine; 2020 Jun 21; 15():5389-5403. PubMed ID: 32801695
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development and optimization of pH-responsive PLGA-chitosan nanoparticles for triggered release of antimicrobials.
    Pola CC, Moraes ARF, Medeiros EAA, Teófilo RF, Soares NFF, Gomes CL.
    Food Chem; 2019 Oct 15; 295():671-679. PubMed ID: 31174811
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.
    Gadhave DG, Quadros M, Ugale AR, Goyal M, Ayehunie S, Gupta V.
    Int J Biol Macromol; 2024 May 15; 267(Pt 2):131491. PubMed ID: 38599435
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers.
    El-Maghawry E, Tadros MI, Elkheshen SA, Abd-Elbary A.
    Int J Nanomedicine; 2020 May 15; 15():3965-3980. PubMed ID: 32606658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.